Rumors have been circulating about mRNA vaccines in livestock. Fact-checkers have been scoffing, but what’s really going on? Could we be eating animals that have been treated with mRNA? How do we know what’s in the meat at our grocery store?
PORK: Yes, it’s probably been treated with mRNA.
Unfortunately, if you’ve been eating pork from the grocery stores, even organic pork, it’s probably been treated with mRNA because pork producers have been using mRNA products since 2018. Merck’s SEQUIVITY platform is used with different sequences of various porcine diseases, including swine flu, to get immune responses in pigs.
Interestingly enough, sow mortality rates have increased slightly, from 11.1% in 2017 to 12.6% in 2021. However, raising animals in large quantities is very complex; increased mortality could be linked to countless factors, and many producers admit they don’t have enough qualified employees to pay optimal attention to animals. The only certainty here is, new pharmaceutical products have not been a magic bullet for the pork industry’s problems.
I guess we, as a society, don’t have enough money for more agricultural and veterinary workers so that hog farmers can optimally monitor the pigs that will become our food. And yet, it’s still full steam ahead with ever-more-complicated bioengineering solutions. A few months ago, GenVax Technologies, a startup that wants to bring self-amplifying mRNA (saRNA) technologies to animal health, received $6.5 million to begin producing vaccines 100% specific to African Swine Fever variants that may be circulating in pork herds. There always seems to be enough money for mRNA.
Sound familiar?
If this sounds similar to a product widely used on humans the past few years, that’s because it is. As in human mRNA treatments, Merck claims that the RNA can’t replicate itself and only lasts a short time in the animals’ bodies. They also say that animals do not shed any RNA particles. Given the wide range of findings in humans after mRNA treatments, however, I think the public has reason to be skeptical.
Now, my first thought when I heard about this was disbelief. Ed Dowd’s Cause Unknown gives very detailed evidence of increasing death rates from the past two years; I couldn’t imagine anyone responsible for livestock trying out a product with so much potential to negatively affect profit margins.
But most people dying from “unknown causes” have not been dropping dead immediately after receiving medical treatments. Many deaths occur weeks or months later. Age dates for pig slaughter vary somewhat, depending on what the pigs are wanted for, but typically range between 4 and 10 months. Pigs’ natural lifespans, however, are between ten and fifteen years, which means that the pigs used for meat are butchered early in their lives. Who knows what we’d see if the pigs reached even 50% of their natural life span?
BEEF: It’s not treated with mRNA. YET.
Regarding beef, the National Cattlemen’s Beef Association has pooh-poohed online talk about the potential for mRNA vaccines being used in beef. They released a statement on April 5, saying, “There are no current mRNA vaccines licensed for use in beef cattle in the United States. Cattle farmers and ranchers do vaccinate cattle to treat and prevent many diseases, but presently none of these vaccines include mRNA technology.”
Okay, but that’s as of April 2023. As Dr. Robert Malone noted recently, there are no transparency laws surrounding animal trials, which means facts and figures are hard to come by. But we do know that German giants Bayer and BioNTech have been working together to develop mRNA vaccines for veterinary use since 2016.
What about chicken?
We know that there is international interest in using an mRNA template to develop a universal flu vaccine for humans, swine, and chickens
We know that there is an RNA vaccine licensed for conditional use in chickens to prevent bird flu.
Confusing, right?
With so much money being pumped into mRNA-related research, are we really supposed to think it’s just not going to go anywhere? The biotech companies readily admit that they want to use mRNA technology to treat various zoonotic diseases and many people are not happy about it; why wouldn’t we all be complaining just because there’s not much licensed at the moment?
The industry does not want clarity.
When Holly Jones introduced Missouri House Bill 1169 there was industry pushback. HB 1169 is a tiny little bill; all it does is mandate reporting on whether or not food products have been treated with gene therapy products. Nothing is banned. The bill simply empowers consumers to make the best choices for themselves and their families.
Free markets can’t function when people can’t make informed choices. The past three years have made many people deeply distrustful of the expert class; they don’t want their food being tampered with. They feel strongly enough about avoiding mRNA-treated meat to be willing to look around and shop carefully. HB 1169 would give these people the knowledge to make informed decisions, and that’s exactly what the pharmaceutical giants and industry lobbyists don’t want.
Industry lobbyists want things to be vague. They want the general public confused and willing to do whatever “the experts” tell them.
During the testimony hearing for HB 1169, industry representatives vehemently opposed the bill. They did not treat any of the public’s concerns as legitimate but insisted that any regulation on biotechnology would make Missouri less competitive for industry. They focused completely on how bad it would look if Missourians seemed skeptical about biotechnology, and how it would negatively impact business in their state.
This should really tell us everything we need to know about the push to get mRNA into our food. It’s all about money for favored industries. They don’t want independent producers providing high-quality food for their communities; they want everyone to be part of the same giant system. This isn’t about health, it isn’t about the environment, it’s about generating new sources of revenue for biotechnology companies.
And they don’t want separate labels because, if something goes wrong and people do start getting sick, or the animals get sick, precise labeling would make it easy to pinpoint the problem.
This is yet another reason why you need to secure your food supply now.
We talk a lot about the importance of securing food supplies on this site, both to avoid novelty products like insects, and also for peace of mind. This most recent revelation about pork products already being treated with mRNA and refusal by industry representatives to address anything other than how HB 1169 will affect the business community should serve as yet another wake up call. We cannot assume anything we buy at the store has not been treated with novel pharmaceutical products.
I know some people will disagree about calling mRNA vaccines “novel products.”
“We’ve been researching mRNA for decades!” I’ll hear. We have not been ingesting these products for decades; we’ve been ingesting them for about five years, without our knowledge, and no one has been monitoring results. This is not enough for me to be confident in their safety, and I don’t think it should be enough for anyone else, either.
I haven’t bought meat from the grocery store in a long time, mostly because I produce a lot myself. Of course, meat production is not practical for everyone, but if it is an option for you, you need to think about it.
And if not, ask yourself, are there farms in your area committed to raising clean meat? There might be. These types of places often have some kind of subscription service and are worth checking out. Even if there is nothing very close, there are some places that ship. Or it might be worth a road trip to get a year’s worth of meat. If you don’t already have good meat sources, now is the best time to start looking for them.
If you live in Missouri, I hope you can raise public awareness about this bill. For those of us that do not, we need to take responsibility for our food choices and start looking for meat sources outside the normal system.
What are your thoughts?
Would it bother you to know that the meat you’re eating has been treated with mRNA technology? If given a clear choice, would you purchase meat with or without these vaccines? What do you think about the cloak of secrecy over the introduction of this into our food supply? How can you avoid mRNA-infused meat? If you can’t raise your own and the labels at the store are not clear, where could you acquire it?
Let’s discuss it in the comments section.
About Marie Hawthorne
A lover of novels and cultivator of superb apple pie recipes, Marie spends her free time writing about the world around her. Article cross-posted from The Organic Prepper.
Why Bullion Beats Numismatics and Collectible for Your Safe or IRA
Precious metals continue to attract Americans seeking reliable ways to protect their wealth amid inflation, geopolitical risks, and stock market swings. Whether stored in a home safe or held inside a self-directed IRA, physical gold and silver deliver tangible value that paper or digital assets often lack. Yet investors must choose carefully between bullion—pure bars and coins valued mainly for their metal content—and numismatics or collectibles, where rarity, history, and collector demand heavily influence pricing.
Advisor Bullion serves as a dependable source for straightforward, high-quality bullion. The company specializes in physical gold, silver, platinum, and palladium, emphasizing transparent pricing and products that deliver maximum metal content for every dollar spent. This approach makes it ideal for both personal holdings and retirement accounts.
Bullion consists of refined precious metals in standard forms like one-ounce coins (American Gold Eagles, Silver Eagles, Canadian Maple Leafs) or bars. Their value tracks closely to the current spot price of the metal. A typical gold bullion coin trades near the live gold spot price plus a small premium. This structure keeps costs clear and predictable.
Numismatic coins and collectibles add substantial value from factors such as age, rarity, minting errors, or historical significance. A pre-1933 U.S. gold coin or graded proof piece can carry premiums of 30%, 50%, or even 200% above melt value. While this appeals to hobbyists, it creates complexity. Pricing depends on subjective grading, collector trends, and auction results instead of daily spot prices.
For investors focused on wealth preservation and retirement security rather than building a collection, bullion often delivers better results.
Lower Costs and Better Liquidity for Home Storage
When keeping metals in a home safe or private vault, liquidity and efficiency count. Bullion offers clear benefits:
- You acquire more actual gold or silver per dollar invested. Numismatics divert a large share of your money into rarity premiums and massive sales commission, reducing your metal exposure.
- Selling bullion involves tight bid-ask spreads, so you recover nearly full spot value with minimal fees. Collectibles require finding the right buyer and may sell at a discount if demand for that specific item weakens.
- Bullion prices remain transparent and update with global spot markets. You can track gold near current levels or silver accordingly and know exactly where your holdings stand. Numismatic values are priced by the Gold IRA companies with hefty margins applied.
- Standardized coins and bars store efficiently and divide easily for partial sales. Rare coins often need protective slabs and controlled conditions, adding hassle and expense.
- Bullion enjoys worldwide acceptance. A 1-oz Gold Maple Leaf or Silver Eagle sells quickly to dealers anywhere. Niche numismatic pieces may appeal only to limited buyers, slowing liquidation when speed matters.
In times when quick access to value becomes important, bullion’s simplicity stands out.
Stronger Fit for Precious Metals IRAs
Precious metals IRAs continue gaining traction as investors diversify retirement portfolios beyond stocks and bonds. IRS rules permit certain bullion products in self-directed IRAs if they meet purity standards (.995 fine for gold, .999 for silver) and are held by an approved custodian. Eligible items include American Gold and Silver Eagles plus many generic bars and rounds from recognized mints.
Numismatic and most collectible coins generally face heavy scrutiny from custodians due to valuation disputes and elevated markups. These higher premiums mean less actual metal ends up working inside the account.
Bullion avoids these issues. Its value links directly to verifiable spot prices, which simplifies reporting and lowers the risk of regulatory challenges. More of your IRA contribution purchases real metal instead of dealer profits or speculative upside. Over time, owning additional ounces that appreciate with the metal itself can create meaningful outperformance compared with high-premium alternatives that deliver fewer ounces.
Regulatory guidance from the CFTC and state securities offices repeatedly cautions against aggressive sales of expensive numismatics or “semi-numismatic” coins for IRAs. For retirement planning, transparent bullion from established providers reduces risk and aligns better with long-term goals.
How to Get Started with Bullion
Begin by clarifying your goals. Are you protecting savings in a safe, or moving part of a retirement account into a precious metals IRA? Focus on the number of ounces you can acquire at current prices rather than chasing marked-up collectibles.
Diversify sensibly: use gold for core preservation and silver for its blend of industrial and monetary qualities. Mix coins for easier divisibility with bars for lower per-ounce costs on larger buys. Arrange secure storage—whether at home with proper insurance or through professional facilities.
As economic uncertainties linger and faith in conventional assets erodes, bullion continues proving its worth as a dependable store of value. Its direct approach avoids the hype that sometimes surrounds collectible markets and keeps the focus on the metal itself.
For investors prepared to strengthen their portfolios, Advisor Bullion supplies the expertise and selection needed to acquire high-quality bullion efficiently. Whether building personal holdings or integrating metals into an IRA, their emphasis on transparent, investment-grade products helps secure more ounces today that support greater financial security tomorrow. In a complicated financial landscape, bullion’s clarity and reliability make it the smarter foundation for protecting what matters most.